Abstract
Rosai-Dorfman disease (RDD) is a rare non-malignant histiocytosis
disorder, commonly manifesting with massive painless cervical
lymphadenopathy. Renal involvement develops in only four percent of
patients with RDD. Generally, RDD is self-limiting and has a good
prognosis; however, in patients with renal involvement, mortality rate
can be as high as 40%.